
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd..
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer1349.HK Technical Analysis Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
This mix signals that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. is trading in a balanced range with no clear breakout yet.
RSI (14): 46.11
Stochastic %K: 66.04
Williams %R: -62.50
Rate of Change (ROC): 4.87
Takeaway:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. shows neutral momentum, with indicators pointing to indecision.
MACD: 0.01
ADX: 38.18
ATR (14): 0.12
CCI (14): -35.13
Takeaway:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. trades closer to support, showing weaker momentum within bands.
Takeaway:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:1349.HK shows mixed signals in money flow analysis.
Bullish Signals
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. are mixed, suggesting a Hold or wait-and-see approach.